Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jae Weon Kim

Showing results (191-200 of 404) with videos related to

Pageof 41
Sort By:
Gynecologic Oncology|October 20, 2006
Clinical impact of integrated PET/CT on the management of suspected cervical cancer recurrenceHyun Hoon Chung, Hoenil Jo, Won Jun Kang, et al.
Gynecologic and Obstetric Investigation|January 29, 2005
Feasibility of radical surgery in the management of elderly patients with uterine cervical cancer in KoreaYoung Sik Choi, Yun Hwan Kim, Sokbom Kang, et al.
BMC Cancer|September 9, 2022
Impact of hemodynamic instability during cytoreductive surgery on survival in high-grade serous ovarian carcinomaSe Ik Kim, Hyung-Chul Lee, Hyun-Kyu Yoon, et al.
Gynecologic Oncology|December 31, 2021
Cervical conization before primary radical hysterectomy has a protective effect on disease recurrence in early cervical cancer: A two-center matched cohort study according to surgical approachSe Ik Kim, Bo Ram Choi, Hee Seung Kim, et al.
BMC Cancer|January 4, 2022
A phase IA dose-escalation study of PHI-101, a new checkpoint kinase 2 inhibitor, for platinum-resistant recurrent ovarian cancerSoo Jin Park, Suk-Joon Chang, Dong Hoon Suh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 23, 2012
Risk assessment tool for distant recurrence after platinum-based concurrent chemoradiation in patients with locally advanced cervical cancer: a Korean gynecologic oncology group studySokbom Kang, Byung-Ho Nam, Jeong-Yeol Park, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 21, 2014
A Web-based nomogram predicting para-aortic nodal metastasis in incompletely staged patients with endometrial cancer: a Korean Multicenter StudySokbom Kang, Jong-Min Lee, Jae-Kwan Lee, et al.
Journal of Gynecologic Oncology|October 25, 2012
How low is low enough? Evaluation of various risk-assessment models for lymph node metastasis in endometrial cancer: a Korean multicenter studySokbom Kang, Jong-Min Lee, Jae-Kwan Lee, et al.
Clinical Nuclear Medicine|January 6, 2023
Development and Validation of 18F-FDG PET/CT-Based Models for Predicting Successful Complete Cytoreduction During Primary Cytoreductive Surgery for Advanced Ovarian cancerJunhwan Kim, Joonhyung Gil, Se Ik Kim, et al.
Clinicoeconomics and Outcomes Research : CEOR|July 23, 2013
Cost-utility analysis for platinum-sensitive recurrent ovarian cancer therapy in South Korea: results of the polyethylene glycolated liposomal doxorubicin/carboplatin sequencing modelHwa-Young Lee, Bong-Min Yang, Ji-Min Hong, et al.
Pageof 41

Showing results (191-200 of 404) with videos related to

Sort By:
Pageof 41
Gynecologic Oncology|October 20, 2006
Clinical impact of integrated PET/CT on the management of suspected cervical cancer recurrenceHyun Hoon Chung, Hoenil Jo, Won Jun Kang, et al.
Gynecologic and Obstetric Investigation|January 29, 2005
Feasibility of radical surgery in the management of elderly patients with uterine cervical cancer in KoreaYoung Sik Choi, Yun Hwan Kim, Sokbom Kang, et al.
BMC Cancer|September 9, 2022
Impact of hemodynamic instability during cytoreductive surgery on survival in high-grade serous ovarian carcinomaSe Ik Kim, Hyung-Chul Lee, Hyun-Kyu Yoon, et al.
Gynecologic Oncology|December 31, 2021
Cervical conization before primary radical hysterectomy has a protective effect on disease recurrence in early cervical cancer: A two-center matched cohort study according to surgical approachSe Ik Kim, Bo Ram Choi, Hee Seung Kim, et al.
BMC Cancer|January 4, 2022
A phase IA dose-escalation study of PHI-101, a new checkpoint kinase 2 inhibitor, for platinum-resistant recurrent ovarian cancerSoo Jin Park, Suk-Joon Chang, Dong Hoon Suh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 23, 2012
Risk assessment tool for distant recurrence after platinum-based concurrent chemoradiation in patients with locally advanced cervical cancer: a Korean gynecologic oncology group studySokbom Kang, Byung-Ho Nam, Jeong-Yeol Park, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 21, 2014
A Web-based nomogram predicting para-aortic nodal metastasis in incompletely staged patients with endometrial cancer: a Korean Multicenter StudySokbom Kang, Jong-Min Lee, Jae-Kwan Lee, et al.
Journal of Gynecologic Oncology|October 25, 2012
How low is low enough? Evaluation of various risk-assessment models for lymph node metastasis in endometrial cancer: a Korean multicenter studySokbom Kang, Jong-Min Lee, Jae-Kwan Lee, et al.
Clinical Nuclear Medicine|January 6, 2023
Development and Validation of 18F-FDG PET/CT-Based Models for Predicting Successful Complete Cytoreduction During Primary Cytoreductive Surgery for Advanced Ovarian cancerJunhwan Kim, Joonhyung Gil, Se Ik Kim, et al.
Clinicoeconomics and Outcomes Research : CEOR|July 23, 2013
Cost-utility analysis for platinum-sensitive recurrent ovarian cancer therapy in South Korea: results of the polyethylene glycolated liposomal doxorubicin/carboplatin sequencing modelHwa-Young Lee, Bong-Min Yang, Ji-Min Hong, et al.
Pageof 41